drugset / Trial / NCT00020878

Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers

NCT00020878 ↗

Phase 2 Completed 21 enrolled Jonsson Comprehensive Cancer Center
NaSingle-groupOpen-labelPrevention

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. Celecoxib may be effective in preventing lung cancer in tobacco smokers. PURPOSE: Phase II trial to study the effectiveness of celecoxib in preventing non-small cell lung cancer in tobacco smokers.

Timeline

Start
2001-03
Primary completion
2002-11
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 400 mg Oral

Indications